Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 305 participants.

Also called NCT04201132

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 305 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04201132
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Bulgaria, Germany, Italy, North Macedonia, Slovenia (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04201132. Allocation not applicable; no masking; primary purpose treatment. Start 2020-06-12 (actual); primary completion 2023-10-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System
Acronym
PERFORMANCE II
Condition
Carotid Artery Stenosis
Condition
Carotid Artery Diseases
Condition
Carotid Stenosis
Intervention (Device)
Carotid artery stenting with Neuroguard IEP System
Lead sponsor
Contego Medical, Inc. (class: industry)
Collaborator
Yale Cardiovascular Research Group (class: other)
Collaborator
Advance Research Associates (class: other)
Collaborator
CardioMed Device Consultants, LLC (class: industry)
Collaborator
IQVIA Pty Ltd (class: industry)
Collaborator
Medidata Solutions (class: industry)

Record details

Record id
cardio:ct-nct04201132
Content hash
7ef2a3c0dda0171d6b3ffd9e70c2f1e6dbecf352ee2030b0ed16ed9382eb19e6